← Back to Search

Vitamins and Minerals

Customized Prenatal Vitamins for Obesity during Pregnancy

N/A
Waitlist Available
Led By SARBATTAMA SEN
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether a prenatal vitamin customized for obese women can help decrease inflammation and stress during pregnancy.

Who is the study for?
This trial is for obese pregnant women or those planning pregnancy with a BMI of 30 kg/m2 or higher. It's not suitable for women who've had multiple early miscarriages, birth defects in previous pregnancies, autoimmune diseases, pre-existing diabetes, severe hypertension, recent smokers, vegans, those on certain medications like anticoagulants or unwilling to stop current supplements.
What is being tested?
The study tests if a special prenatal vitamin tailored to body mass index (BMI) can reduce inflammation and oxidative stress in obese pregnant women better than the standard prenatal vitamin. The goal is to see if this new approach leads to healthier outcomes for both mother and child.
What are the potential side effects?
While specific side effects are not detailed here as it's about vitamins intake adjustment based on BMI; generally speaking potential side effects may include gastrointestinal discomfort or allergic reactions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Maternal systemic marker of inflammation
Maternal systemic marker of oxidative stress
Secondary study objectives
Breastfeeding intensity
Cord blood marker of inflammation
Cord blood markers of oxidative stress
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InvestigativeExperimental Treatment1 Intervention
This arm receives a standard prenatal (provided by the study) and a micronutrient supplement.
Group II: ControlActive Control1 Intervention
Standard prenatal vitamin provided by the study

Find a Location

Who is running the clinical trial?

Beth Israel Deaconess Medical CenterOTHER
861 Previous Clinical Trials
12,932,680 Total Patients Enrolled
21 Trials studying Obesity
634 Patients Enrolled for Obesity
Brigham and Women's HospitalLead Sponsor
1,670 Previous Clinical Trials
11,878,120 Total Patients Enrolled
47 Trials studying Obesity
277,978 Patients Enrolled for Obesity
SARBATTAMA SENPrincipal InvestigatorBrigham and Women's Hospital

Media Library

BMI-based prenatal vitamin (Vitamins and Minerals) Clinical Trial Eligibility Overview. Trial Name: NCT02802566 — N/A
Obesity Research Study Groups: Investigative, Control
Obesity Clinical Trial 2023: BMI-based prenatal vitamin Highlights & Side Effects. Trial Name: NCT02802566 — N/A
BMI-based prenatal vitamin (Vitamins and Minerals) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02802566 — N/A
~13 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top